When a patient needs a bone marrow or stem cell transplant, choosing the right donor is one of the most critical decisions. Doctors look for many factors to ensure the best outcome, but some markers are just beginning to show their true importance. Recent data suggests that a specific genetic marker called the KIR B/X genotype in the donor can make a significant difference.
Researchers looked at 17 different studies involving patients who underwent allogeneic hematopoietic stem cell transplant_s. They found that patients who received transplants from donors with the KIR B/X genotype had significantly better overall survival rates compared to those who did not. This finding suggests that this specific genetic marker could help doctors pick the best possible donor for their patients.
It is important to remember that these results show a strong link between the gene and survival, but they do not prove that one causes the other directly. Because this data comes from observational studies rather than a controlled trial, it serves as a helpful guide for identifying potential biomarkers during the selection process.
